Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
USE OF 2,4-PYRIMIDINEDIAMINES FOR THE TREATMENT OF ATHEROSCLEROSIS
No-Receipt date
2017-00197 - 19/01/2017
No-Filing date
20170400172 - 19/01/2017
No-Granting date
3091262 - 17/03/2017
No-EPO application date
09711944.0 - 20/02/2009
No-EPO granting date
2252300 - 19/10/2016
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
3/2017 - 15/05/2017
Expiration date
21/02/2029
Kind of title
Validation of European Patent
Legal status
NOT VALID
Priorities
US3090322/02/2008/US
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
A61P 9/10
A61K 31/662
A61K 31/5383
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
727208
RIGEL PHARMACEUTICALS, INC.
1180 VETERANS BOULEVARD
SOUTH SAN FRANCISCO, CA 94080
UNITED STATES OF AMERICA (USA)
Inventors
Code
Firstname
Surname
1782702
MASUDA, ESTEBAN
1782703
SCHMITZ, JOCHEN
Representatives
Code
Firstname
Surname
Address
Town
Zip
1602
AIKATERINI
SIOTOU
PATISION 122
ATHINA (ATTIKIS)
11257
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
4766
AIKATERINI
SIOTOU
PATISION (28IS OKTOVRIOU) 122
ATHINA (ATTIKIS)
11257
GREECE
Owners History
Title Instruments
Date
Operation
Descreption
9/4/2024 12:00:00 AM
Έκπτωση Κύριων Τίτλων (79602)
ΕΚΠΤΩΣΕΙΣ 08/2024 Αρ.Πρωτ. ΓΔ 2433/04.09.2024
Payments history
15 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).